Modified Sijunzi Decoction Inhibits Epithelial-Mesenchymal Transition of Non-Small Cell Lung Cancer by Attenuating AKT/GSK3β Pathway in vitro and in vivo

Modified Sijunzi Decoction (MSJZD) is an empirical prescription of Traditional Chinese Medicine (TCM) and has been corroborated to be effective in multiple human diseases, but its role in non-small cell lung cancer (NSCLC) is enigmatic. Here we mainly analyze the function and mechanism of MSJZD in N...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Niu, Xiao, Yao, Zhang, Jiaxin, Zhu, Yuying, Wang, Shenglong, Bao, Suzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802809/
https://www.ncbi.nlm.nih.gov/pubmed/35111070
http://dx.doi.org/10.3389/fphar.2021.821567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802809/
https://www.ncbi.nlm.nih.gov/pubmed/35111070
http://dx.doi.org/10.3389/fphar.2021.821567

Ejemplares similares